(BrJ7 Ophthalmol 1996;80:509-5 14) Idiopathic intracranial hypertension (IIH), also known as pseudotumour cerebri and benign intracranial hypertension, is a disorder of elevated intracranial pressure of unknown cause. Since the only permanent morbidity from IIH is loss of vision, the current knowledge of the disease indicates that its course must be carefully followed by investigat ment of refractive status, best corrected visual acuity determination, slit-lamp examination, applanation tonometry, ophthalmoscopy, standardised A-scan echography of the optic nerve, and automated static perimetry. All the patients showed radiological evidence of an empty sella, a non-specific finding often associated with the disease, either at x ray of the skull in the region of the sella turcica or on computed tomography (CT) and magnetic resonance imaging (MRI) scans. Whereas skull x rays often demonstrated an enlarged sella, CT scans of the head revealed an area isodense to CSF almost completely filling an enlarged sella, with the pituitary gland flattened against the sellar floor or walls. MRI scans confirmed the diagnosis of primary empty sella syndrome. Concomitant systemic alterations, such as obesity, recent weight gain, and endocrine dysfunction were present in some cases. None of the patients was under treatment at the time of examination. The most commonly reported symptoms were headache with or without associated vomiting or nausea (14 cases, 70%), transient visual obscurations (11 cases, 55%), vertigo (five cases, 25%), visual loss (one case, 5%), photopsias (one case, 5%), and diplopia (one case, 5%). All but two eyes had normal corrected Snellen visual acuity (20/20 or better). Intraocular pressures ranged from 12 to 20 mm Hg. Direct ophthalmoscopic and biomicroscopic assessment of the degree of papilloedema, based on the staging scheme proposed by Frisen, (stage 0: normal optic disc, to stage 5: marked disc swelling with anterior expansion of the nerve head),26
showed bilateral papilloedema (ranging from stage 1 to 4) in 10 patients; one patient had papilloedema in only one eye (stage 3), and nine patients showed no signs of optic disc oedema in either eye. No concomitant ocular diseases were clinically evident.
Echographic measurements of transverse OND were performed on the same day as the automated testing, using a Mini A standardised echographic unit (Biophysics Medical), using a technique already described in the literature.2' Clinical accuracy in repeated measurements of optic nerve in the mid orbit is 0.03-0.05 mm; measurement accuracy provided by the equipment is 0.01 mm. Briefly, the probe was placed on the temporal ocular surface, and different optic nerve scans behind the globe were obtained. In the present study optic nerve diameters were measured midway between the nerve's insertion at the bulb and its passage through the orbital apex (intermediate optic nerve section). With the eye in the primary position, the echographic A-scan display of a maximally wide defect representing the lower reflective optic nerve as well as steeply rising or falling surface spikes (corresponding to the lateral and nasal arachnoid surfaces of the optic nerve sheaths) indicates the maximum diameter of the optic nerve in the area scanned by the beam. At increased intracranial pressure, as in patients with IIH, these subarachnoidal surfaces can be visualised even more clearly because of the volume of liquid separating them from the underlying nerve tissue.
Computerised representing a direct positive relation between OND measurements along the intraorbital portion and diastolic intracranial pressure over 15 mm Hg, and based on normal intracranial pressure values, they could define an echographic biometric range of normal ONDs."4 Of the eyes included in the present study, 19 out of 40 (47%) had significantly increased OND values. Interestingly, three out of these 19 eyes (15.8%) had no papilloedema at clinical examination. Since our patients had increased CSF pressure as documented by a lumbar puncture, we may presume that in some cases of IIH the distension of the optic nerve sheaths, as a result of elevated CSF pressure and detectable by optic nerve echography, could precede the appearance of a clinically evident papilloedema. The present finding in some way stresses the value of standardised A-scan echography in the morphological examination of the optic nerve in IIH.
Various studies recommend the clinical evaluation of patients with IIH by automated perimetry. This technique allows the detection of functional changes, such as the development of initial perimetric defects or the eventual progression of the disease. In our sample, all patients presented with a primary empty sella syndrome and IIH with or without papilloedema. Visual loss in these patients may be explained by two mechanisms related to papilloedema and/or empty sella. As to papilloedema, several studies have reported evidence that the anterior optic nerve is the site of the lesions. Functional damage, indeed, is associated with a optic disc oedema due to the transmission of the increased intracranial pressure through the neural sheaths. Early visual loss in patients with IIH with papilloedema has been related to a nerve conduction defect secondary to the stasis of axoplasmic flow in retinal ganglion cells and/or a compression induced ischaemia of the same cells.27 As to those patients who do not have papilloedema, different mechanisms leading to visual loss have been suggested. Foley and Posner have described many patients with empty sella and increased intracranial pressure without papilloedema.'5 They suggested that (1) papilloedema is less frequent in the combined syndrome than in IIH alone, and (2) visual field defects and visual loss are more likely when IIH and the primary empty sella syndrome appear together than when either occurs independently. Visual complaints were explained, indeed, by the presence of both chronic elevation of intracranial pressure and an incompetent diaphragma sellae which produces herniation of the subarachnoid cistern into the sella turcica, with the resultant stretching of the optic nerves or chiasm. According to this mechanism, the eventual absence of papilloedema may occur because pressure on the optic nerves occluded the subarachnoid pathways leading to the optic discs. Other hypotheses were postulated for the lack of papilloedema such as the probable presence of congenital or acquired optic nerve sheaths defects, 'chronic pseudotumour cerebri' with resolution of papilloedema, or intermittent elevation of intracranial pressure below the threshold to produce papilloedema."9 Wall and George used perimetry in order to follow the clinical evolution of IIH but mainly to decide the treatment.5 In fact they confirmed other recents observations that in the individual patients' symptoms and the degree of papilloedema (except for the high grade and/or atrophic papilloedema) may not correlate with loss of visual function.5 20 On the other hand, automated perimetry of the central 30 degrees seems to be able to detect early functional defects in IIH, with high sensitivity and specificity. '9 The findings obtained in the present study indicate the OND changes in IIH are associated, at least in part, with perimetric threshold alterations, and suggest that IIH functional deficits may be related to the degree of distension of optic nerve sheaths as the result of an increase in CSF pressure. In conclusion, transverse OND evaluation using echographic techniques may be useful not only for morphological analysis, but also to provide indications of the associated visual loss in IIH. This approach may be of potential clinical value for establishing the timing and methods of treatment. Indeed, treatment of IIH focuses on the early detection and prevention of visual loss.
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